BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20410925)

  • 1. High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression.
    Boultwood J; Perry J; Zaman R; Fernandez-Santamaria C; Littlewood T; Kusec R; Pellagatti A; Wang L; Clark RE; Wainscoat JS
    Leukemia; 2010 Jun; 24(6):1139-45. PubMed ID: 20410925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p.
    Nakai H; Misawa S; Toguchida J; Yandell DW; Ishizaki K
    Cancer Res; 1992 Dec; 52(23):6588-93. PubMed ID: 1423304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays.
    Wang L; Fidler C; Nadig N; Giagounidis A; Della Porta MG; Malcovati L; Killick S; Gattermann N; Aul C; Boultwood J; Wainscoat JS
    Haematologica; 2008 Jul; 93(7):994-1000. PubMed ID: 18508791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysis.
    Bullinger L; Krönke J; Schön C; Radtke I; Urlbauer K; Botzenhardt U; Gaidzik V; Carió A; Senger C; Schlenk RF; Downing JR; Holzmann K; Döhner K; Döhner H
    Leukemia; 2010 Feb; 24(2):438-49. PubMed ID: 20016533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11.
    Flotho C; Steinemann D; Mullighan CG; Neale G; Mayer K; Kratz CP; Schlegelberger B; Downing JR; Niemeyer CM
    Oncogene; 2007 Aug; 26(39):5816-21. PubMed ID: 17353900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide high density single-nucleotide polymorphism array-based karyotyping improves detection of clonal aberrations including der(9) deletion, but does not predict treatment outcomes after imatinib therapy in chronic myeloid leukemia.
    Huh J; Jung CW; Kim JW; Kim HJ; Kim SH; Shin MG; Kim YK; Kim HJ; Suh JS; Moon JH; Sohn SK; Nam GH; Lee JE; Kim DH
    Ann Hematol; 2011 Nov; 90(11):1255-64. PubMed ID: 21384125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases.
    Grossmann V; Kohlmann A; Zenger M; Schindela S; Eder C; Weissmann S; Schnittger S; Kern W; Müller MC; Hochhaus A; Haferlach T; Haferlach C
    Leukemia; 2011 Mar; 25(3):557-60. PubMed ID: 21274004
    [No Abstract]   [Full Text] [Related]  

  • 8. Frequent occurrence of uniparental disomy in colorectal cancer.
    Andersen CL; Wiuf C; Kruhøffer M; Korsgaard M; Laurberg S; Ørntoft TF
    Carcinogenesis; 2007 Jan; 28(1):38-48. PubMed ID: 16774939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomewide screening of DNA copy number changes in chronic myelogenous leukemia with the use of high-resolution array-based comparative genomic hybridization.
    Hosoya N; Sanada M; Nannya Y; Nakazaki K; Wang L; Hangaishi A; Kurokawa M; Chiba S; Ogawa S
    Genes Chromosomes Cancer; 2006 May; 45(5):482-94. PubMed ID: 16425296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
    Okabe M
    Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of the myeloid transcription factor CEBPA are not associated with the blast crisis of chronic myeloid leukaemia.
    Pabst T; Stillner E; Neuberg D; Nimer S; Willman CL; List AF; Melo JV; Tenen DG; Mueller BU
    Br J Haematol; 2006 May; 133(4):400-2. PubMed ID: 16643447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance.
    Inokuchi K; Yamaguchi H; Tarusawa M; Futaki M; Hanawa H; Tanosaki S; Dan K
    Leukemia; 2002 Feb; 16(2):170-7. PubMed ID: 11840282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic alterations in the p53 gene in the blast crisis of chronic myelogenous leukemia: analysis by polymerase chain reaction based techniques.
    Neubauer A; He M; Schmidt CA; Huhn D; Liu ET
    Leukemia; 1993 Apr; 7(4):593-600. PubMed ID: 8464238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia.
    Lehmann S; Ogawa S; Raynaud SD; Sanada M; Nannya Y; Ticchioni M; Bastard C; Kawamata N; Koeffler HP
    Cancer; 2008 Mar; 112(6):1296-305. PubMed ID: 18246537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients.
    Marega M; Piazza RG; Pirola A; Redaelli S; Mogavero A; Iacobucci I; Meneghetti I; Parma M; Pogliani EM; Gambacorti-Passerini C
    Leukemia; 2010 Aug; 24(8):1445-9. PubMed ID: 20520635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia.
    Makishima H; Jankowska AM; McDevitt MA; O'Keefe C; Dujardin S; Cazzolli H; Przychodzen B; Prince C; Nicoll J; Siddaiah H; Shaik M; Szpurka H; Hsi E; Advani A; Paquette R; Maciejewski JP
    Blood; 2011 May; 117(21):e198-206. PubMed ID: 21346257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic imbalances in CML blast crisis: 8q24.12-q24.13 segment identified as a common region of over-representation.
    Gribble SM; Reid AG; Roberts I; Grace C; Green AR; Nacheva EP
    Genes Chromosomes Cancer; 2003 Aug; 37(4):346-58. PubMed ID: 12800146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of programmed cell death proteins in patients with chronic myeloid leukemia.
    Strnad M; Brajuskovic G; Strelic N; Todoric-Zivanovic B; Stamatovic D; Tatomirovic Z; Magic Z
    J BUON; 2008; 13(3):403-8. PubMed ID: 18979557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
    Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
    Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of N-ras mutations in myeloid and lymphoid blast crisis of chronic myeloid leukemia.
    Watzinger F; Gaiger A; Karlic H; Becher R; Pillwein K; Lion T
    Cancer Res; 1994 Jul; 54(14):3934-8. PubMed ID: 8033117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.